Here, we established a myeloid cell-specific SIRT1 conditional knockout (Sirt1fl/fl-LysMCre) mouse model of asthma using ovalbumin (OVA) induction and determined the underlying mechanism by which the SIRT1 agonist bergenin acts in the treatment of asthma. The gene discussed is SIRT1; the disease is asthma.